Skip to main content

Secondary Lung Cancer

  • Chapter
  • First Online:
Image-Guided Interventions in Oncology

Abstract

Lung metastases are identified in 30–55% of all cancer patients and are the second most frequent site of metastatic spread for colorectal and breast cancer. Thermal ablation such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation of lung oligometastasis is a viable substitute for radiation therapy and surgical resection in appropriately selected patients. In this chapter, we discuss the current evidence supporting the use of thermal ablation in patients with pulmonary oligometastasis, technical considerations of the procedure, patient selection, potential complications, and reported outcomes. Additionally, we will discuss the data for surgery and radiation therapy on the oligometastatic patient and how ablation can fit into the paradigm.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CIRSE:

Cardiovascular and Interventional Radiology Society of Europe

CRC:

Colorectal cancer

EGFR-TKI:

Epidermal growth factor receptor tyrosine kinase inhibitors

GGO:

Ground-glass opacity

LCT:

Local consolidative therapy

MWA:

Microwave ablation

OS:

Overall survival

PET/CT:

Positron-emission tomography/computed tomography

PFS:

Progression-free survival

RFA:

Radiofrequency ablation

SBRT:

Stereotactic body radiotherapy

SCC:

Squamous cell carcinoma

References

  1. Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9(7):621–8.

    Article  PubMed  Google Scholar 

  2. Clark GM, Sledge GW, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol. 1987;5(1):55–61.

    Article  CAS  PubMed  Google Scholar 

  3. Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, Erinjeri J, Petre EN, Gonen M, et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol [Internet]. 2018;41(10):1530–44.. Available from: https://doi.org/10.1007/s00270-018-2000-6.

    Article  CAS  Google Scholar 

  4. Kaneda H, Saito Y. Oligometastases: defined by prognosis and evaluated by cure. Cancer Treat Commun. 2015;3:1–6.

    Article  Google Scholar 

  5. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol [Internet]. 1995;13(1):8–10.. Available from: https://doi.org/10.1200/JCO.1995.13.1.8.

    Article  CAS  Google Scholar 

  6. Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113(1):37–49.

    Article  CAS  PubMed  Google Scholar 

  7. Kondo H, Okumura T, Ohde Y, Nakagawa K. Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcomes. Int J Clin Oncol. 2005;10(2):81–5.

    Article  PubMed  Google Scholar 

  8. Casiraghi M, De Pas T, Maisonneuve P, Brambilla D, Ciprandi B, Galetta D, et al. A 10-year single-center experience on 708 lung metastasectomies: the evidence of the “international registry of lung metastases”. J Thorac Oncol [Internet]. 2011;6(8):1373–8.. Available from: https://doi.org/10.1097/JTO.0b013e3182208e58.

    Article  Google Scholar 

  9. Yu HA, Sima CS, Huang J, Solomon SB, Rimner A, Paik P, et al. Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors. J Thorac Oncol [Internet]. 2013;8(3):346–51.. Available from: https://doi.org/10.1097/JTO.0b013e31827e1f83.

    Article  CAS  Google Scholar 

  10. Klement RJ, Hoerner-Rieber J, Adebahr S, Andratschke N, Blanck O, Boda-Heggemann J, et al. Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy. Radiother Oncol [Internet]. 2018;127(2):246–52.. Available from: https://doi.org/10.1016/j.radonc.2018.02.016.

    Article  CAS  Google Scholar 

  11. Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Jack Lee J, et al. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol. 2019;37(18):1558–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2009;73(1):112–8.

    Article  PubMed  Google Scholar 

  13. Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2012;118(11):2962–70.

    Article  PubMed  Google Scholar 

  14. Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010;76(3):796–801.

    Article  PubMed  Google Scholar 

  15. Pereira PL, Salvatore M. Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors. Cardiovasc Intervent Radiol. 2012;35(2):247–54.

    Article  PubMed  Google Scholar 

  16. Dempsey PJ, Ridge CA, Solomon SB. Advances in interventional oncology: lung cancer. Cancer J (United States). 2016;22(6):393–400.

    Google Scholar 

  17. Palussière J, Catena V, Buy X. Percutaneous thermal ablation of lung tumors – radiofrequency, microwave and cryotherapy: where are we going? Diagn Interv Imaging [Internet]. 2017;98(9):619–25.. Available from: https://doi.org/10.1016/j.diii.2017.07.003.

    Article  Google Scholar 

  18. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time” approach. Cancer. 2003;97(12):3027–35.

    Article  PubMed  Google Scholar 

  19. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309‐321. https://doi.org/10.1097/00000658-199909000-00004.

  20. De Baere T, Tselikas L, Catena V, Buy X, Deschamps F, Palussière J. Percutaneous thermal ablation of primary lung cancer. Diagn Interv Imaging [Internet]. 2016;97(10):1019–24.. Available from: https://doi.org/10.1016/j.diii.2016.08.016.

    Article  Google Scholar 

  21. Abtin F, De Baere T, Dupuy DE, Genshaft S, Healey T, Khan S, et al. Updates on current role and practice of lung ablation. J Thorac Imaging. 2019;34(4):266–77.

    Article  PubMed  Google Scholar 

  22. Hiraki T, Gobara H, Fujiwara H, Ishii H, Tomita K, Uka M, et al. Lung cancer ablation: complications. Semin Intervent Radiol. 2013;30(2):169–75.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Smith SL, Jennings PE. Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances. Br J Radiol. February 2015; 88(1046): 20140598. Published online 2015 Jan 12. https://doi.org/10.1259/bjr.20140598PMCID:PMC4614249.

  24. Kashima M, Yamakado K, Takaki H, Kodama H, Yamada T, Uraki J, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences. Am J Roentgenol. 2011;197(4):576–80.

    Article  Google Scholar 

  25. Zheng A, Wang X, Yang X, Wang W, Huang G, Gai Y, et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg [Internet]. 2014;98(1):243–8.. Available from: https://doi.org/10.1016/j.athoracsur.2014.03.008.

    Article  Google Scholar 

  26. Chheang S, Abtin F, Guteirrez A, Genshaft S, Suh R. Imaging features following thermal ablation of lung malignancies. Semin Intervent Radiol. 2013;30(2):157–68.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Palussière J, Marcet B, Descat E, Deschamps F, Rao P, Ravaud A, et al. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol. 2011;34(5):989–97.

    Article  PubMed  Google Scholar 

  28. Ridge CA, Solomon SB. Percutaneous ablation of colorectal lung metastases. J Gastrointest Oncol. 2015;6(6):685–92.

    PubMed  PubMed Central  Google Scholar 

  29. De Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26(5):987–91.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Petre EN, Jia X, Thornton RH, Sofocleous CT, Alago W, Kemeny NE, et al. Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clin Colorectal Cancer [Internet]. 2013;12(1):37–44.. Available from: https://doi.org/10.1016/j.clcc.2012.07.003.

    Article  Google Scholar 

  31. Vogl TJ, Naguib NNN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NEA. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology. 2011;261(2):643–51.

    Article  PubMed  Google Scholar 

  32. De Baere T, Tselikas L, Woodrum D, Abtin F, Littrup P, Deschamps F, et al. Evaluating cryoablation of metastatic lung tumors in patients-safety and efficacy the ECLIPSE trial-interim analysis at 1 year. J Thorac Oncol [Internet]. 2015;10(10):1468–74.. Available from: https://doi.org/10.1097/JTO.0000000000000632.

    Article  Google Scholar 

  33. Inoue Y, Miki C, Hiro J, Ojima E, Yamakado K, Takeda K, et al. Improved survival using multi-modality therapy in patients with lung metastases from colorectal cancer: a preliminary study. Oncol Rep. 2005;14(6):1571–6.

    PubMed  Google Scholar 

  34. Rao P, Escudier B, De Baere T. Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis. Cardiovasc Intervent Radiol. 2011;34(2):424–30.

    Article  PubMed  Google Scholar 

  35. McArthur HL, Diab A, Page DB, Yuan J, Solomon SB, Sacchini V, et al. A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling. Clin Cancer Res. 2016;22(23):5729–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eduardo A. Lacayo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lacayo, E.A., Solomon, S., Ho, A. (2020). Secondary Lung Cancer. In: Georgiades, C., Kim, H. (eds) Image-Guided Interventions in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-48767-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-48767-6_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-48766-9

  • Online ISBN: 978-3-030-48767-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics